| Not Yet Recruiting | Molecular Breast Imaging (MBI)-Guided Biopsy NCT07114679 | Smart Breast Corp. | N/A |
| Not Yet Recruiting | Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients NCT07273812 | Dena h. Al-Tameemi | N/A |
| Recruiting | Surviving Daily Life NCT07054723 | Thomas Jefferson University | — |
| Recruiting | Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as W NCT06294574 | University of Alabama at Birmingham | N/A |
| Recruiting | CRYoablation for Small Tumors As Local Treatment - SIX Trial NCT06839001 | Hospital do Coracao | Phase 3 |
| Recruiting | Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer NCT05949983 | University Hospital, Toulouse | N/A |
| Recruiting | A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood t NCT06672302 | EXoPERT | — |
| Active Not Recruiting | Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor NCT06255808 | Seoul National University Hospital | — |
| Active Not Recruiting | KNUCH CadAI-B-1(KCB-1) NCT06622967 | JeeYeon Lee | N/A |
| Recruiting | Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy NCT06268665 | University of California, Davis | Phase 2 |
| Recruiting | Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care NCT06630962 | Northwestern University | N/A |
| Recruiting | Cryoablation vs Lumpectomy in T1 Breast Cancers NCT05505643 | Washington University School of Medicine | N/A |
| Completed | Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation NCT06056414 | Centre Henri Becquerel | N/A |
| Recruiting | Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. NCT06072612 | BriaCell Therapeutics Corporation | Phase 3 |
| Completed | HOBBIT 3: Mental Exercises and Temporal Alteration NCT06100068 | University Hospital, Ghent | N/A |
| Recruiting | A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer NCT06075810 | MBQ Pharma | Phase 1 |
| Not Yet Recruiting | The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC NCT05862610 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Active Not Recruiting | A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Pati NCT05889988 | Mayo Clinic | — |
| Recruiting | Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan NCT06805812 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Recruiting | Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer NCT05020860 | Baylor Breast Care Center | Phase 2 |
| Recruiting | Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. NCT06090747 | Instituto Nacional de Cancerologia de Mexico | N/A |
| Completed | CanRestoreFunction Cancer-related Fatigue ( CRF ) NCT05868187 | University of Cincinnati | N/A |
| Recruiting | SNF Platform Study of HR+/ HER2-advanced Breast Cancer NCT05594095 | Fudan University | Phase 2 |
| Withdrawn | Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in NCT03426254 | Center Trials & Treatment | Phase 1 |
| Recruiting | Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy NCT05582499 | Fudan University | Phase 2 |
| Completed | Factor Influencing Breast Surgery Type Decision-Making NCT05604677 | Etienne El Helou | — |
| Active Not Recruiting | Lymphaticovenous Anastomosis as Treatment for Lymphedema NCT05441943 | Odense University Hospital | N/A |
| Active Not Recruiting | Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study NCT05309265 | Azienda USL Reggio Emilia - IRCCS | N/A |
| Active Not Recruiting | Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Can NCT05169567 | Eli Lilly and Company | Phase 3 |
| Completed | Project Breast47: Effect of an Educational Intervention NCT05267171 | University of Oviedo | N/A |
| Unknown | Surgical Pre-habilitation in Breast Cancer. NCT04861220 | Instituto Nacional de Cancer, Brazil | N/A |
| Completed | Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO) NCT04583124 | Universidad de Granada | N/A |
| Recruiting | Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities NCT06058650 | Mayo Clinic | N/A |
| Completed | Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors NCT05364450 | Indiana University | N/A |
| Completed | Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Car NCT04444882 | University Hospital, Grenoble | — |
| Completed | Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization NCT04893421 | Sunnybrook Health Sciences Centre | N/A |
| Completed | Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadj NCT06212440 | National Cancer Center, Korea | N/A |
| Completed | Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups NCT04767464 | Mary Radomski | N/A |
| Completed | Regional Anesthesia and Partial Mastectomy NCT04824599 | Karlstad Central Hospital | N/A |
| Active Not Recruiting | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors NCT04660929 | Carisma Therapeutics Inc | Phase 1 |
| Recruiting | Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program NCT04652609 | Universidad de Granada | N/A |
| Unknown | Ultrasonographic Axillary Localization NCT04644848 | Mansoura University | N/A |
| Completed | Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors NCT04640220 | Yeungnam University Hospital | N/A |
| Recruiting | Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast C NCT05427071 | The University of Hong Kong | N/A |
| Completed | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors NCT03935282 | Wake Forest University Health Sciences | N/A |
| Active Not Recruiting | TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer NCT04489173 | Borstkanker Onderzoek Groep | Phase 2 |
| Completed | Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilie NCT05576545 | Kaohsiung Medical University Chung-Ho Memorial Hospital | N/A |
| Unknown | Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia NCT05050890 | Instituto Brasileiro de Controle do Cancer | — |
| Terminated | Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer NCT04305236 | University of California, Irvine | Phase 2 |
| Completed | The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast Reconstruction NCT04440995 | Yonsei University | N/A |
| Completed | Real-life Pan-HER-blockade With Neratinib NCT04388384 | Pierre Fabre Pharma GmbH | — |
| Completed | Non-mass Enhancement in Breast MRI NCT04083027 | Assiut University | — |
| Unknown | Circulating Tumor Cells Screen for Breast Cancer NCT05633680 | Handan First Hospital | — |
| Recruiting | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study NCT03740893 | Institute of Cancer Research, United Kingdom | Phase 2 |
| Recruiting | Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring NCT04799535 | Mayo Clinic | — |
| Completed | Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome NCT03761420 | St. Olavs Hospital | — |
| Completed | Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra NCT03868514 | pfm medical gmbh | — |
| Completed | Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer NCT03874598 | Universität Duisburg-Essen | N/A |
| Unknown | Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pil NCT03939598 | Aga Khan University | — |
| Completed | Aspects of Breast-conserving Surgery NCT04227613 | Lund University | — |
| Active Not Recruiting | MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or NCT03881605 | Sunnybrook Health Sciences Centre | N/A |
| Completed | The Genetic Education for Men Trial: Web-Based Education vs. Standard Care NCT02957981 | Georgetown University | N/A |
| Withdrawn | Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography NCT03266562 | Mayo Clinic | N/A |
| Completed | Anlotinib in Metastatic HER2 Negative Breast Cancer NCT04002284 | Peng Yuan | Phase 2 |
| Completed | G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast C NCT03455270 | G1 Therapeutics, Inc. | Phase 1 |
| Completed | Combination Study of SV-BR-1-GM With Retifanlimab NCT03328026 | BriaCell Therapeutics Corporation | Phase 1 / Phase 2 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers NCT03013881 | United BioPharma | Phase 1 |
| Completed | Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE® NCT03445637 | Pfizer | — |
| Terminated | Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy NCT03740984 | Dr. Horst Schmidt Klinik GmbH | N/A |
| Unknown | A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outc NCT03275727 | Linkoeping University | Phase 2 / Phase 3 |
| Completed | Testing of the Cancer Thriving and Surviving Breast Cancer Program NCT03651921 | Manuela Eicher | N/A |
| Completed | Effectiveness of a Modern Educational Intervention in Breast Cancer Patients NCT03351075 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Unknown | Giving Information on the Risks and Limitations of Mammography Screening (GIRLS) NCT02914197 | McMaster University | N/A |
| Completed | Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surg NCT03330717 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Terminated | Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC NCT03295552 | Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Terminated | EPR Tumor Oximetry With CE India Ink NCT03321903 | Philip Schaner | — |
| Completed | Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surger NCT03202472 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy NCT03280836 | Milton S. Hershey Medical Center | N/A |
| Unknown | The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast NCT03024463 | Shandong Cancer Hospital and Institute | — |
| Terminated | Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and NCT03220178 | Palleos Healthcare GmbH | Phase 4 |
| Completed | Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management NCT02992782 | University of Alberta | N/A |
| Completed | SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer NCT03066947 | BriaCell Therapeutics Corporation | Phase 1 / Phase 2 |
| Active Not Recruiting | Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer NCT03141437 | M.D. Anderson Cancer Center | N/A |
| Active Not Recruiting | Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer NCT03269981 | Samsung Medical Center | N/A |
| Completed | RISAS Procedure in Node Positive Breast Cancer Following NAC NCT02800317 | Erasmus Medical Center | N/A |
| Unknown | A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer NCT03024580 | Instituto Nacional de Cancer, Brazil | Phase 2 |
| Completed | Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) NCT02950259 | Providence Health & Services | Phase 1 |
| Terminated | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple NCT02978716 | G1 Therapeutics, Inc. | Phase 2 |
| Completed | Presentation of First Time Attenders at Lymphedema Clinics NCT03687749 | Universitaire Ziekenhuizen KU Leuven | — |
| Terminated | Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM) NCT03008031 | Maastricht University Medical Center | N/A |
| Unknown | G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locall NCT02983071 | G1 Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting NCT03069742 | Columbia University | N/A |
| Completed | SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer NCT02970682 | Evgen Pharma | Phase 2 |
| Completed | Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy. NCT03273426 | Seoul National University Hospital | N/A |
| Unknown | Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction NCT02913573 | Huntington Memorial Hospital | Phase 2 |
| Completed | Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer NCT03124095 | Federal University of Pelotas | N/A |
| Unknown | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life NCT03000192 | University Hospital Southampton NHS Foundation Trust | — |
| Unknown | Laser Fluorescence in Cancer Surgical Treatment NCT03021200 | Instituto do Cancer do Estado de São Paulo | N/A |
| Withdrawn | Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery NCT02372305 | University of Arkansas | Phase 4 |
| Active Not Recruiting | Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer NCT02455141 | Shanghai Jiao Tong University School of Medicine | Phase 3 |
| Completed | Breast Edema Compression Vest NCT02627976 | UMC Utrecht | N/A |
| Completed | Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL NCT02609724 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Withdrawn | Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injecti NCT02610920 | Columbia University | EARLY_Phase 1 |
| Unknown | Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention NCT02318615 | Peking University People's Hospital | N/A |
| Unknown | Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and NCT03606369 | Instituto Nacional de Cancerologia de Mexico | Phase 2 / Phase 3 |
| Active Not Recruiting | [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer NCT02608216 | University of Pennsylvania | Phase 1 |
| Terminated | 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients NCT02602067 | sigma-tau i.f.r. S.p.A. | Phase 1 |
| Unknown | Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment NCT03625635 | Humberto Francisco Astiazaran Garcia, PhD | N/A |
| Completed | Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participan NCT02513472 | Eisai Inc. | Phase 1 / Phase 2 |
| Completed | [18F]FES PET/CT in Endocrine Refractory Breast Cancer NCT02409316 | University of Pennsylvania | Phase 2 |
| Withdrawn | Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing Lumpectomy NCT02432118 | Stanford University | N/A |
| Completed | The Preemptive Analgesic Efficacy of Nefopam NCT02561468 | Seoul National University Bundang Hospital | N/A |
| Active Not Recruiting | [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer NCT02284919 | University of Pennsylvania | Phase 1 |
| Unknown | SAVI SCOUT Clinical Evaluation Study NCT02370082 | Cianna Medical, Inc. | N/A |
| Completed | Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer NCT02316561 | UMC Utrecht | N/A |
| Terminated | Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast NCT01755130 | M.D. Anderson Cancer Center | N/A |
| Unknown | Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer NCT02065960 | Juravinski Cancer Center | Phase 1 |
| Completed | Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment NCT02061085 | MedSIR | Phase 2 |
| Active Not Recruiting | Proton Radiation for Stage II/III Breast Cancer NCT01758445 | Proton Collaborative Group | Phase 2 |
| Recruiting | Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer NCT01766297 | Proton Collaborative Group | Phase 2 |
| Completed | Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer H NCT02056080 | MedSIR | — |
| Completed | The Impact of Physical Activity on the Outcome of Surgery NCT01707121 | Sahlgrenska University Hospital | — |
| Terminated | Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment NCT01596530 | AstraZeneca | Phase 1 |
| Completed | Assessing the Patient Experience in Cancer Care NCT01621295 | Mayo Clinic | — |
| Completed | Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib NCT01466972 | Hope Rugo, MD | Phase 2 |
| Terminated | Study of AFP464 +/- Faslodex in ER + Breast Cancer NCT01233947 | Tigris Pharmaceuticals | Phase 2 |
| Unknown | Tesetaxel as First-line Therapy for Metastatic Breast Cancer NCT01221870 | Genta Incorporated | Phase 2 |
| Completed | Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer NCT01199393 | Peking University Cancer Hospital & Institute | — |
| Withdrawn | Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer NCT01015521 | Tigris Pharmaceuticals | Phase 2 |
| Completed | Health Benefits of Expressive Writing: Study One NCT03546673 | University of Houston | N/A |
| Terminated | A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer NCT00771381 | AHS Cancer Control Alberta | Phase 2 |
| Terminated | Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 A NCT00638963 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment NCT01859936 | Karolinska University Hospital | Phase 4 |
| Completed | Multipeptide Vaccine for Advanced Breast Cancer NCT00573495 | University of Pennsylvania | Phase 1 |
| Unknown | FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer NCT01432002 | University Hospital, Geneva | — |
| Completed | Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer NCT00530868 | University of Alabama at Birmingham | Phase 2 |
| Completed | Yoga to Reduce Cancer Fatigue NCT00583739 | University of Iowa | Phase 2 |
| Completed | Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER NCT00550771 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Post-treatment Care of Breast Cancer Survivors NCT00821288 | Columbia University | N/A |
| Completed | Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone R NCT00463788 | Merck KGaA, Darmstadt, Germany | Phase 2 |
| Completed | A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With NCT00736333 | Merck Sharp & Dohme LLC | — |
| Completed | Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer NCT00313248 | Bayer | Phase 2 |
| Terminated | Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study NCT00779285 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Optimizing Body Composition & Health After Breast Cancer NCT00659906 | OHSU Knight Cancer Institute | N/A |
| Completed | Strength Training for Older Breast Cancer Survivors NCT00591747 | OHSU Knight Cancer Institute | N/A |
| Completed | Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients NCT00270894 | Accelerated Community Oncology Research Network | Phase 2 |
| Terminated | A Study of MLN8054 in Patients With Advanced Solid Tumors NCT00249301 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Terminated | Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast NCT00251095 | Achieve Life Sciences | Phase 3 |
| Completed | A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Brea NCT00687440 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians NCT00295529 | University of Toronto | N/A |
| Completed | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC NCT00201435 | Norwegian Breast Cancer Group | Phase 2 / Phase 3 |
| Completed | Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women NCT00107016 | Novartis Pharmaceuticals | Phase 2 |
| Completed | A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Met NCT00779129 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 NCT00034281 | Takeda | Phase 1 |
| Completed | Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer NCT00194727 | University of Washington | Phase 2 |
| Completed | Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly T NCT00194753 | University of Washington | Phase 2 |
| Completed | Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignan NCT00831545 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer NCT00005908 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer NCT00005655 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Microarray Analysis for Human Genetic Disease NCT00001898 | National Human Genome Research Institute (NHGRI) | — |
| Completed | Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer NCT01061359 | Pfizer | — |
| Completed | Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients NCT00001837 | National Institutes of Health Clinical Center (CC) | — |
| Completed | Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer NCT00194740 | University of Washington | Phase 2 |
| Completed | Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer NCT00001507 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients NCT00001504 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer NCT00001496 | National Cancer Institute (NCI) | — |
| Completed | Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of V NCT00001440 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective NCT00001250 | National Cancer Institute (NCI) | Phase 2 |